Brazil: Model for success?
Brazil's successful policy of making cheap copies of patented AIDS drugs hasn't been copied by other developing countries. In Sao Paulo, Andre Muggiati finds out why not.
[This feature was produced as part of the id21 project.]
Date published: 02/09/2003
Duration of spoken feature: 00:05:00
Studio in: Last week at the UN AIDS conference in Barcelona, the
Brazilian government issued a challenge to the international
pharmaceutical industry. It unveiled a plan to help other developing countries manufacture cheap copies of AIDS drugs.
The plan draws widely from Brazil's own experience since the
mid-nineties, when it became the first country to sidestep patent laws on AIDS drugs by making their own version in state-owned laboratories.
The policy has had huge success, enabling Brazil to distribute drugs free of charge to people living with HIV and AIDS, and to drastically reduce its AIDS death rate. Yet, until now, no other country has adopted the same policy - and today only 4 per cent of people living with HIV and AIDS in the developing world receive any drugs.
A report from the international organisation, VSO, investigates why other countries have been unable to follow Brazil's example until now.
From Sao Paulo, Andre Muggiati, reports.
AuthorReporter: Andre Muggiati (Sao Paulo) - Music: Wolfgang Schubart :::> w.schubart(AT)web.de